BIO-PATH HOLDINGS, INC. Income Statement
BPTH|7 years of annual SEC 10-K data (FY2012-FY2018)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
BIO-PATH HOLDINGS, INC. reported $0 in revenue and $9M in net loss for FY2018. Revenue increased 184.6% from FY2016 to FY2017.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -25.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $37.0K | $13.0K | $0 | $0 | $0 | $0 |
| SG&A Expense | $3.4M | $3.5M | $3.0M | $2.5M | $2.7M | $1.6M | $986.1K |
| R&D Expense | $4.6M | $5.5M | $5.5M | $3.0M | $1.6M | $1.5M | $1.1M |
| Operating Income | -$8.6M | -$9.0M | -$8.5M | -$5.5M | -$4.5M | -$3.3M | -$2.6M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$8.6M | -$7.0M | -$6.8M | -$5.5M | -$4.5M | -$3.3M | -$2.6M |
| EPS (Diluted) | -$15.99 | -$0.73 | -$0.05 | -$0.05 | -$0.04 | -$0.04 | -$0.04 |
| Shares Outstanding | 567 | 9.6K | 89.8M | 89.8M | 62.2M | 62.2M | 58.3M |
| Operating Margin | - | -24232.4% | -65192.3% | - | - | - | - |
| Profit Margin | - | -18981.1% | -51923.1% | - | - | - | - |